ECO 2026 12 - 15 May 2026

Early Responders to Oral Semaglutide 25 mg: A Post Hoc Analysis of the OASIS 4 Trial

Authors :

W. Timothy Garvey¹; Oscar Birkhan²; Naveen Rathor²; Chaithra Shaji³; Domenica Rubino⁴

Affiliations

View Details Hide Details

{{ getPageNum(PDFPage) }}

Download .PDF

Keywords

Obesity

Congress poster

GLP-1 RA

Semaglutide (oral)

PHASE 3 (RCT)